The aftermath of AKI: Recurrent AKI, acute kidney disease, and CKD progression

Yumeng Wen; Chirag R. Parikh

doi:10.1681/ASN.2020091317

The aftermath of AKI: Recurrent AKI, acute kidney disease, and CKD progression

Yumeng Wen, Chirag R. Parikh

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2-4
Number of pages	3
Journal	Journal of the American Society of Nephrology
Volume	32
Issue number	1
DOIs	https://doi.org/10.1681/ASN.2020091317
State	Published - Jan 2021

ASJC Scopus subject areas

Nephrology

Access to Document

10.1681/ASN.2020091317

Cite this

@article{4c8b75467c9944409c7cf679f6280ebd,

title = "The aftermath of AKI: Recurrent AKI, acute kidney disease, and CKD progression",

author = "Yumeng Wen and Parikh, {Chirag R.}",

note = "Funding Information: D. Friedman reports receiving National Institutes of Health grants MD007092 and MD014726, and Department of Defense grant W81XWH2010826; being a coinventor on patents related to APOL1 diagnostics and therapeutics, awarded to Beth Israel Deaconess Medical Center; having an ownership interest in Apolo1Bio; and having consultancy agreements with, and receiving research funding from, Vertex, outside the submitted work. Funding Information: C. Parikh was supported by National Institutes of Health grants R01DK-93770 and R01HL-085757, and is also participating in the National Institute of Diabetes and Digestive and Kidney Diseases-sponsored Kidney Precision Medicine Project UH3DK114866.",

year = "2021",

month = jan,

doi = "10.1681/ASN.2020091317",

language = "English (US)",

volume = "32",

pages = "2--4",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "American Society of Nephrology",

number = "1",

}

TY - JOUR

T1 - The aftermath of AKI

T2 - Recurrent AKI, acute kidney disease, and CKD progression

AU - Wen, Yumeng

AU - Parikh, Chirag R.

N1 - Funding Information: D. Friedman reports receiving National Institutes of Health grants MD007092 and MD014726, and Department of Defense grant W81XWH2010826; being a coinventor on patents related to APOL1 diagnostics and therapeutics, awarded to Beth Israel Deaconess Medical Center; having an ownership interest in Apolo1Bio; and having consultancy agreements with, and receiving research funding from, Vertex, outside the submitted work. Funding Information: C. Parikh was supported by National Institutes of Health grants R01DK-93770 and R01HL-085757, and is also participating in the National Institute of Diabetes and Digestive and Kidney Diseases-sponsored Kidney Precision Medicine Project UH3DK114866.

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85098566820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098566820&partnerID=8YFLogxK

U2 - 10.1681/ASN.2020091317

DO - 10.1681/ASN.2020091317

M3 - Editorial

C2 - 33037129

AN - SCOPUS:85098566820

SN - 1046-6673

VL - 32

SP - 2

EP - 4

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 1

ER -

The aftermath of AKI: Recurrent AKI, acute kidney disease, and CKD progression

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this